PROKIDNEY CORP.

Prokidney Corp.

Biotechnology • Healthcare • Winston-Salem, NC, United States • PROK (NCM)

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

336 999 7028 2000 Frontis Plaza Blvd., Winston-Salem, NC 27103, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

ProKidney (NASDAQ:PROK) Stock Price Down 4.3% - What's Next? - MarketBeat
MarketBeat • Dec 19
$PROK stock is down 12% today. Here's what we see in our data. - Quiver Quantitative
Quiver Quantitative • Dec 29
H.C. Wainwright initiates ProKidney stock with Buy rating, $12 target - Investing.com
Investing.com • Dec 16
ProKidney Corp. (PROK) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Yahoo Finance • Jul 16
US Stocks Recap: Will PROK stock benefit from upcoming earnings reports - 2025 Sector Review & Real-Time Stock Price Movement Reports - moha.gov.vn
moha.gov.vn • Jan 2

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has PROKIDNEY CORP. had layoffs?
No layoff events have been recorded for PROKIDNEY CORP. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does PROKIDNEY CORP. have?
PROKIDNEY CORP. has approximately 204 employees.
What industry is PROKIDNEY CORP. in?
PROKIDNEY CORP. operates in the Biotechnology industry, within the Healthcare sector.
Is PROKIDNEY CORP. a publicly traded company?
Yes, PROKIDNEY CORP. is publicly traded under the ticker symbol PROK on the NCM. The company has a market capitalization of approximately $0.76 billion.
Where is PROKIDNEY CORP. headquartered?
PROKIDNEY CORP. is headquartered in Winston-Salem, NC, United States at 2000 Frontis Plaza Blvd., Winston-Salem, NC 27103, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.